Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rieckmann

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Journal of Neurology|September 26, 2006
Socio-economic aspects of neuroimmunological diseasesPeter Rieckmann
Der Nervenarzt|December 1, 2006
[Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)], Peter Rieckmann
Journal of Neurology|November 19, 2004
Improving MS patient carePeter Rieckmann
Journal of the Neurological Sciences|February 10, 2009
Concepts of induction and escalation therapy in multiple sclerosisPeter Rieckmann
International MS Journal|January 19, 2006
Neurodegeneration and clinical relevance for early treatment in multiple sclerosisPeter Rieckmann
Current Opinion in Neurology|June 5, 2002
Anti-inflammatory strategies to prevent axonal injury in multiple sclerosisPeter Rieckmann, Mathias Mäurer
Drugs|July 31, 2003
Early intervention in multiple sclerosis : better outcomes for patients and society?Peter Flachenecker, Peter Rieckmann
MMW Fortschritte Der Medizin|January 29, 2010
[Practical advice for a safe, effective and well tolerated therapy of multiple sclerosis]Mathias Buttmann, Peter Rieckmann
Expert Review of Neurotherapeutics|March 8, 2007
Interferon-beta1b in multiple sclerosisMathias Buttmann, Peter Rieckmann
Current Opinion in Neurology|May 29, 2004
Health outcomes in multiple sclerosisPeter Flachenecker, Peter Rieckmann
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Journal of Neurology|September 26, 2006
Socio-economic aspects of neuroimmunological diseasesPeter Rieckmann
Der Nervenarzt|December 1, 2006
[Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)], Peter Rieckmann
Journal of Neurology|November 19, 2004
Improving MS patient carePeter Rieckmann
Journal of the Neurological Sciences|February 10, 2009
Concepts of induction and escalation therapy in multiple sclerosisPeter Rieckmann
International MS Journal|January 19, 2006
Neurodegeneration and clinical relevance for early treatment in multiple sclerosisPeter Rieckmann
Current Opinion in Neurology|June 5, 2002
Anti-inflammatory strategies to prevent axonal injury in multiple sclerosisPeter Rieckmann, Mathias Mäurer
Drugs|July 31, 2003
Early intervention in multiple sclerosis : better outcomes for patients and society?Peter Flachenecker, Peter Rieckmann
MMW Fortschritte Der Medizin|January 29, 2010
[Practical advice for a safe, effective and well tolerated therapy of multiple sclerosis]Mathias Buttmann, Peter Rieckmann
Expert Review of Neurotherapeutics|March 8, 2007
Interferon-beta1b in multiple sclerosisMathias Buttmann, Peter Rieckmann
Current Opinion in Neurology|May 29, 2004
Health outcomes in multiple sclerosisPeter Flachenecker, Peter Rieckmann
Pageof 13